Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): In-Country Development of H5N1 Influenza Vaccines in Vietnam, Program Announcement Number CI06-008

---
identifier: "/us/fr/06-98"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): In-Country Development of H5N1 Influenza Vaccines in Vietnam, Program Announcement Number CI06-008"
title_number: 0
title_name: "Federal Register"
section_number: "06-98"
section_name: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): In-Country Development of H5N1 Influenza Vaccines in Vietnam, Program Announcement Number CI06-008"
positive_law: false
currency: "2006-01-06"
last_updated: "2006-01-06"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "06-98"
document_type: "notice"
publication_date: "2006-01-06"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "71 FR 935"
fr_volume: 71
---


#  Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): In-Country Development of H5N1 Influenza Vaccines in Vietnam, Program Announcement Number CI06-008

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting:

*Name* : Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): In-Country Development of H5N1 Influenza Vaccines in Vietnam, Program Announcement Number CI06-008.

*Times and Dates* : 11 a.m.-1 p.m., January 23, 2006 (Closed).

*Place* : Teleconference.

*Status* : The meeting will be closed to the public in accordance with provisions set forth in section 5523b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

*Matters to be Discussed* : The meeting will include the review, discussion, and evaluation of applications received in response to: In-Country Development of H5N1 Influenza Vaccines in Vietnam, Program Announcement Number CI06-008.

**FOR FURTHER INFORMATION CONTACT:**

Mary Lerchen, Dr.P.H., Associate Director, Office of Public Health Research, Centers for Disease Control and Prevention, 1600 Clifton Road, NE., Mailstop D-72, Atlanta, GA 30030, Telephone (404) 639-4897.

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: December 30, 2005.

Alvin Hall,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.